- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/28 - 2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Patent holdings for IPC class C07D 207/28
Total number of patents in this class: 84
10-year publication summary
8
|
8
|
10
|
8
|
7
|
3
|
4
|
2
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 4863 |
7 |
Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet | 134 |
4 |
Sunshine Lake Pharma Co., Ltd. | 570 |
4 |
H. Lundbeck A/S | 1249 |
4 |
Dow Global Technologies LLC | 10156 |
3 |
Ajinomoto Co., Inc. | 2319 |
3 |
Biogen MA Inc. | 914 |
3 |
NanoSynthons LLC | 7 |
3 |
Xwpharma Ltd. | 59 |
3 |
Boehringer Ingelheim International GmbH | 4754 |
2 |
Bayer Schering Pharma AG | 429 |
2 |
ALFASIGMA S.p.A. | 506 |
2 |
Dainippon Sumitomo Pharma Co., Ltd. | 211 |
2 |
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | 89 |
2 |
Vectivbio Comet AG | 6 |
2 |
Glaxo Group Limited | 4281 |
1 |
Novartis AG | 11254 |
1 |
F. Hoffmann-La Roche AG | 7942 |
1 |
Merck Sharp & Dohme Corp. | 2219 |
1 |
Janssen Pharmaceutica N.V. | 3612 |
1 |
Other owners | 33 |